» Articles » PMID: 30295127

RBM-5 Modulates U2AF Large Subunit-dependent Alternative Splicing in C. Elegans

Overview
Journal RNA Biol
Specialty Molecular Biology
Date 2018 Oct 9
PMID 30295127
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

A key step in pre-mRNA splicing is the recognition of 3' splicing sites by the U2AF large and small subunits, a process regulated by numerous trans-acting splicing factors. How these trans-acting factors interact with U2AF in vivo is unclear. From a screen for suppressors of the temperature-sensitive (ts) lethality of the C. elegans U2AF large subunit gene uaf-1(n4588) mutants, we identified mutations in the RNA binding motif gene rbm-5, a homolog of the tumor suppressor gene RBM5. rbm-5 mutations can suppress uaf-1(n4588) ts-lethality by loss of function and neuronal expression of rbm-5 was sufficient to rescue the suppression. Transcriptome analyses indicate that uaf-1(n4588) affected the expression of numerous genes and rbm-5 mutations can partially reverse the abnormal gene expression to levels similar to that of wild type. Though rbm-5 mutations did not obviously affect alternative splicing per se, they can suppress or enhance, in a gene-specific manner, the altered splicing of genes in uaf-1(n4588) mutants. Specifically, the recognition of a weak 3' splice site was more susceptible to the effect of rbm-5. Our findings provide novel in vivo evidence that RBM-5 can modulate UAF-1-dependent RNA splicing and suggest that RBM5 might interact with U2AF large subunit to affect tumor formation.

Citing Articles

Maize splicing-mediated mRNA surveillance impeded by sugarcane mosaic virus-coded pathogenic protein NIa-Pro.

Du K, Peng D, Wu J, Zhu Y, Jiang T, Wang P Sci Adv. 2024; 10(34):eadn3010.

PMID: 39178251 PMC: 11343020. DOI: 10.1126/sciadv.adn3010.


Study of prognostic splicing factors in cancer using machine learning approaches.

Yang M, Liu J, Kim P, Zhou X Hum Mol Genet. 2024; 33(13):1131-1141.

PMID: 38538560 PMC: 11190612. DOI: 10.1093/hmg/ddae047.


Characterising the RNA-binding protein atlas of the mammalian brain uncovers RBM5 misregulation in mouse models of Huntington's disease.

Mullari M, Fossat N, Skotte N, Asenjo-Martinez A, Humphreys D, Bukh J Nat Commun. 2023; 14(1):4348.

PMID: 37468457 PMC: 10356804. DOI: 10.1038/s41467-023-39936-x.


RNA-Binding Motif Protein 11 (RBM11) Serves as a Prognostic Biomarker and Promotes Ovarian Cancer Progression.

Fu C, Yuan M, Sun J, Liu G, Zhao X, Chang W Dis Markers. 2021; 2021:3037337.

PMID: 34434291 PMC: 8382552. DOI: 10.1155/2021/3037337.


The NALCN Channel Regulator UNC-80 Functions in a Subset of Interneurons To Regulate Reversal Behavior.

Zhou C, Luo J, He X, Zhou Q, He Y, Wang X G3 (Bethesda). 2019; 10(1):199-210.

PMID: 31690562 PMC: 6945035. DOI: 10.1534/g3.119.400692.


References
1.
Jurica M, Moore M . Pre-mRNA splicing: awash in a sea of proteins. Mol Cell. 2003; 12(1):5-14. DOI: 10.1016/s1097-2765(03)00270-3. View

2.
Mourtada-Maarabouni M, Keen J, Clark J, Cooper C, Williams G . Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. Exp Cell Res. 2006; 312(10):1745-52. DOI: 10.1016/j.yexcr.2006.02.009. View

3.
Timmer T, Terpstra P, van den Berg A, Veldhuis P, Elst A, van der Veen A . An evolutionary rearrangement of the Xp11.3-11.23 region in 3p21.3, a region frequently deleted in a variety of cancers. Genomics. 1999; 60(2):238-40. DOI: 10.1006/geno.1999.5878. View

4.
Ramaswamy S, Ross K, Lander E, Golub T . A molecular signature of metastasis in primary solid tumors. Nat Genet. 2002; 33(1):49-54. DOI: 10.1038/ng1060. View

5.
OBryan M, Clark B, McLaughlin E, DSylva R, ODonnell L, Wilce J . RBM5 is a male germ cell splicing factor and is required for spermatid differentiation and male fertility. PLoS Genet. 2013; 9(7):e1003628. PMC: 3723494. DOI: 10.1371/journal.pgen.1003628. View